ATE456955T1 - Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen - Google Patents
Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungenInfo
- Publication number
- ATE456955T1 ATE456955T1 AT05801277T AT05801277T ATE456955T1 AT E456955 T1 ATE456955 T1 AT E456955T1 AT 05801277 T AT05801277 T AT 05801277T AT 05801277 T AT05801277 T AT 05801277T AT E456955 T1 ATE456955 T1 AT E456955T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclodextrin
- treat
- inflammatory disease
- bronchial inflammatory
- prevent bronchial
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1
- -1 cyclodextrin compound Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04104957A EP1655034A1 (de) | 2004-10-10 | 2004-10-10 | Verwendung von Cyclodextrin zur Behandlung und Vorbeugung von entzündlichen Bronchialerkrankungen. |
| PCT/EP2005/054966 WO2006037769A1 (en) | 2004-10-10 | 2005-09-30 | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE456955T1 true ATE456955T1 (de) | 2010-02-15 |
Family
ID=34929683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05801277T ATE456955T1 (de) | 2004-10-10 | 2005-09-30 | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7829550B2 (de) |
| EP (2) | EP1655034A1 (de) |
| JP (1) | JP4989481B2 (de) |
| AT (1) | ATE456955T1 (de) |
| DE (1) | DE602005019247D1 (de) |
| ES (1) | ES2340511T3 (de) |
| PL (1) | PL1799231T3 (de) |
| WO (1) | WO2006037769A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9545424B2 (en) | 2007-06-01 | 2017-01-17 | SolAero Med Inc. | Method of treating pulmonary surfactant dysfunction or respiratory distress syndrome by administering cyclodextrin or a derivative thereof |
| EP2600864B1 (de) * | 2010-08-04 | 2019-01-09 | University Of Virginia Patent Foundation | Zusammensetzungen und verfahren zur behandlung von entzündungskrankheiten |
| CN107865968B (zh) | 2012-08-03 | 2021-03-05 | 美国政府(由卫生和人类服务部的部长所代表) | 用于治疗溶酶体贮积症的环糊精 |
| RU2506080C1 (ru) * | 2012-09-25 | 2014-02-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО НижГМА Минздравсоцразвития России) | Способ лечения и профилактики осложнений в полости рта, вызванных приемом ингаляционных гормональных препаратов у больных бронхиальной астмой |
| JP6181188B2 (ja) * | 2012-09-27 | 2017-08-16 | ソールエアロメッド インク． | コレステロール捕捉シクロデキストリンを用いた肺表面活性物質機能障害の治療 |
| FR3014694B1 (fr) | 2013-12-13 | 2016-11-11 | Roquette Freres | Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl |
| NZ724902A (en) * | 2014-03-28 | 2023-03-31 | Univ Liege | Composition comprising cyclodextrin and budesonide derivatives for the treatment and prophylaxis of pulmonary inflammations |
| EP2923702A1 (de) * | 2014-03-28 | 2015-09-30 | Universite De Liege | Zusammensetzung von Cyclodextrin mit Budesonidderivaten zur Behandlung und Vorbeugung von entzündlichen Lungenerkrankungen |
| EP3307278A4 (de) | 2015-06-10 | 2018-06-13 | Vtesse, Inc. | Hydroxypropyl-beta-cyclodextrin-zusammensetzungen und verfahren |
| CN112334494A (zh) | 2018-06-29 | 2021-02-05 | 罗盖特公司 | 新颖的羟丙基-β-环糊精及其生产方法 |
| FR3083234B1 (fr) * | 2018-06-29 | 2020-11-27 | Roquette Freres | Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation |
| BE1027425B1 (fr) * | 2019-07-01 | 2021-02-08 | Aquilon Pharmaceuticals | Composition inhalable comprenant de la cyclodextrine a utiliser dans le traitement d’inflammations nasales |
| BE1027612B1 (fr) | 2019-09-10 | 2021-05-03 | Aquilon Pharmaceuticals | Microparticules en forme de balle de golf pour une utilisation dans le traitement et la prevention de maladies pulmonaires |
| US11045434B1 (en) | 2020-04-01 | 2021-06-29 | UNION therapeutics A/S | Niclosamide formulations for treating disease |
| MA53516A1 (fr) * | 2020-06-15 | 2022-04-29 | Univ Liege | Cyclodextrine utilisée dans le traitement et la prévention de la bronchoconstriction en phase tardive de l'asthme provoqué par des allergènes. |
| WO2023118014A1 (en) | 2021-12-20 | 2023-06-29 | Aquilon Pharmaceuticals | Inhalable compositions comprising a complex of hpbcd and budesonide or ciclesonide for the treatment or prevention of a respiratory viral disease or lipopolysaccharide-induced inflammation, in particular lipopolysaccharide-induced inflammation associated with a respiratory viral disease |
| BE1030002B1 (fr) | 2021-12-29 | 2023-09-01 | Aquilon Pharmaceuticals | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire |
| KR20240160120A (ko) | 2022-02-18 | 2024-11-08 | 베렌 테라퓨틱스 피.비.씨. | 하이드록시프로필-베타-사이클로덱스트린의 조성물 및 이의 정제 방법 |
| BE1031693B1 (fr) | 2023-06-07 | 2025-01-23 | Aquilon Pharmaceuticals | Compositions sans conservateur comprenant un complexe de corticostéroïde et d'hpbcd pour le traitement ou la prévention d'une maladie inflammatoire par administration nasale |
| WO2024251923A1 (en) | 2023-06-07 | 2024-12-12 | Aquilon Pharmaceuticals | Preservative-free compositions comprising a complex of a corticosteroid and hpbcd for the treatment or prevention of an inflammatory disease through nasal administration |
| BE1031691B1 (fr) | 2023-06-07 | 2025-01-23 | Aquilon Pharmaceuticals | Compositions sans conservateur comprenant un complexe de corticostéroïde et d'hpbcd pour le traitement ou la prévention d'une maladie inflammatoire par administration nasale |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4054736A (en) * | 1970-06-10 | 1977-10-18 | Ono Pharmaceutical Co., Ltd. | Clathrate compounds of prostaglandins or their analogues with cyclodextrin |
| JPS62123132A (ja) * | 1985-11-21 | 1987-06-04 | Michio Nakanishi | 気管支喘息治療用組成物 |
| JPS62292719A (ja) * | 1986-06-12 | 1987-12-19 | Kaken Pharmaceut Co Ltd | 外用澄明水溶性製剤 |
| US5254541A (en) * | 1991-11-15 | 1993-10-19 | Merck Frosst Canada, Inc. | (Quinolin-2-ylmethoxy)indole/cyclodextrin complex |
| US5840713A (en) * | 1995-04-03 | 1998-11-24 | Weisz; Paul B. | Therapy for tissue membrane insufficiency |
| AU4717997A (en) * | 1996-10-28 | 1998-05-22 | Farmarc Nederland Bv | Inclusion complexes of beta-2-andrenergics for oral mucosal delivery |
| JP2006008568A (ja) * | 2004-06-24 | 2006-01-12 | Cyclochem:Kk | ＩｇＥ抗体抑制剤および食品 |
-
2004
- 2004-10-10 EP EP04104957A patent/EP1655034A1/de not_active Withdrawn
-
2005
- 2005-09-30 WO PCT/EP2005/054966 patent/WO2006037769A1/en not_active Ceased
- 2005-09-30 PL PL05801277T patent/PL1799231T3/pl unknown
- 2005-09-30 JP JP2007535148A patent/JP4989481B2/ja not_active Expired - Fee Related
- 2005-09-30 US US11/664,999 patent/US7829550B2/en active Active
- 2005-09-30 EP EP05801277A patent/EP1799231B1/de not_active Expired - Lifetime
- 2005-09-30 ES ES05801277T patent/ES2340511T3/es not_active Expired - Lifetime
- 2005-09-30 AT AT05801277T patent/ATE456955T1/de active
- 2005-09-30 DE DE602005019247T patent/DE602005019247D1/de not_active Expired - Lifetime
-
2010
- 2010-07-29 US US12/846,241 patent/US20110028432A1/en not_active Abandoned
-
2012
- 2012-05-23 US US13/478,743 patent/US20120295872A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20120295872A1 (en) | 2012-11-22 |
| EP1799231B1 (de) | 2010-02-03 |
| JP2008515847A (ja) | 2008-05-15 |
| US7829550B2 (en) | 2010-11-09 |
| US20110028432A1 (en) | 2011-02-03 |
| PL1799231T3 (pl) | 2010-07-30 |
| EP1655034A1 (de) | 2006-05-10 |
| ES2340511T3 (es) | 2010-06-04 |
| DE602005019247D1 (de) | 2010-03-25 |
| JP4989481B2 (ja) | 2012-08-01 |
| EP1799231A1 (de) | 2007-06-27 |
| US20090012041A1 (en) | 2009-01-08 |
| WO2006037769A1 (en) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005019247D1 (de) | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen | |
| ATE440866T1 (de) | Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten | |
| ATE519488T1 (de) | Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten | |
| EP1851237A4 (de) | Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen | |
| ATE480543T1 (de) | Tetrahydropyrrolopyrimidindione und ihre verwendung als inhibitoren der humanen neutrophilen elastase | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| DE602006019838D1 (de) | Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten | |
| DE60303238D1 (de) | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten | |
| EP1916964A4 (de) | Implantate und verfahren zur behebung, ersetzung und behandlung von gelenkkrankheiten | |
| EP2007393A4 (de) | Thiazol- und thiophen-analoga sowie ihre verwendung zur behandlung von autoimmunerkrankungen und karzinomen | |
| ATE390925T1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| ATE369333T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
| ATE534391T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen | |
| DE602005002930D1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| ATE447551T1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
| DE602006018057D1 (de) | Substituierte chinolone und verwendungsverfahren | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| CY1114760T1 (el) | Θεραπευτικη αγωγη αθηροσκληρωσης | |
| DE602006003415D1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von proliferativen krankheiten oder entzündungen | |
| ATE446754T1 (de) | Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten | |
| EP1965827A4 (de) | Behandlung von entmyelinisierenden erkrankungen | |
| EP1905452A4 (de) | Wirkstoff zur prävention oder behandlung von glaukomen | |
| DE502006007982D1 (de) | Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1799231 Country of ref document: EP |